Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

GenoMed launches campaign to improve patient outcomes for diabetes, high blood pressure and emphysema

GenoMed, Inc., a Next Generation DM™ (Disease Management) company that uses its expertise in genomics to improve clinical outcomes, announced today the launch of its national marketing campaign to improve patient outcomes for diabetes, high blood pressure and emphysema.

7 Jun 2004

Men with low prostate specific antigen levels on screening tests can still have prostate cancer

Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study* released today by scientists from the National Cancer Institute (NCI).

27 May 2004

Call to bring cancer genomics from the lab bench into large-scale clinical trials

Professor Patrick Johnston is one of a number of pioneering scientists exploring how intimate genetic knowledge from individual tumours could help doctors predict which treatments will benefit their patients best. Major trials of this approach – which has shown considerable success in the lab – are needed to test its full predictive potential.

24 May 2004

WHO to tackle heart disease, diabetes, cancers, road safety as well as diseases

The World Health Assembly, the supreme decision-making body of the World Health Organization, has raised global public health to a new level, by resolving to take more action to prevent death and illness resulting from heart disease, diabetes, cancers, road safety, and lack of access to health services as well as from diseases spread by viruses, bacteria and other dangerous microbes.

22 May 2004

Genome research sheds light on Bardet-Biedl syndrome

By comparing the genomes of an alga, a weed and humans, a team of researchers has identified a new gene behind Bardet-Biedl syndrome (BBS), a complex condition marked by learning disabilities, vision loss and obesity.

21 May 2004

New 100 teraflop supercomputer will help simulation of brain seizures

The U.S. Department of Energy's Argonne National Laboratory will play a major role in the development of a new national computational science facility aimed at deploying a supercomputer capable of sustained performance of 100 trillion floating-point operations per second (teraflops) by 2007.

21 May 2004

Genome Quebec Innovation Centre has announced the signing of a service agreement with GenoMed

The McGill University and Genome Quebec Innovation Centre has announced the signing of a service agreement with GenoMed, a US company located in St. Louis, Missouri that specializes in using genomics to practice better medicine.

19 May 2004

Want a new type of man? Maybe less brawn and more brains?

A new version of the human male is a distinct possibility, given the genetic erosion of the “junk” sex-determining chromosome that makes men male.

17 May 2004

Vitamin discovery offers clues for cancer chemotherapy

NH-Dartmouth Medical School cancer researchers, in a fusion of biochemistry and genetics, have discovered a new vitamin in a molecular pathway central to such vital processes as gene regulation, metabolism and aging. And, they found that milk contains this nutrient.

15 May 2004

Genomed treatment helps bald eagles with West Nile virus encephalitis

GenoMed, Inc. a Next Generation Disease Management company that uses its expertise in genomics to improve clinical outcomes in as many species as possible, announced today that two non-profit groups which care for wild birds with West Nile virus encephalitis, including American bald eagles, will be using the Company's patent-pending treatment this season.

13 May 2004

Biochip technology to revolutionise the pharmaceutical industry

Advancements in biotechnology have culminated in its integration with semiconductor technologies such as micro-electromechanical systems, resulting in the evolution of biochips. Biochips provide pharma companies with sophisticated tools for speedy development of drugs and accurate diagnosis and understanding of biological mechanisms.

13 May 2004

Ingenium's acquisition of US patents may lead to drug discovery and development

Ingenium Pharmaceuticals AG has acquired outright US patents no. 5,994,075 and no. 6,015,670 from Incyte Corporation, the company announced today.

12 May 2004

Sharing functional magnetic resonance imaging (fMRI) data is quickly becoming a reality

The dream of saving and sharing functional magnetic resonance imaging (fMRI) data is quickly becoming a reality, according to Dartmouth researchers who run the fMRI Data Center, which archives and distributes the raw data from studies that track brain activity using fMRI.

11 May 2004

Faster technique for extracting DNA

A computer scientist at Washington University in St. Louis has developed a novel technique to extract more DNA from a single sequence reaction than is normally possible, reducing both cost and time of the sequencing process.

10 May 2004

Europe-wide network fighting heart disease

Academic expertise at the University of Birmingham's Medical School is contributing to a Europe-wide network fighting heart disease. The European Vascular Genomics Network (EVGN) is the first European Funded network of excellence in the field of cardiovascular disease.

10 May 2004

Belarus to collaborate with GenoMed on West Nile virus encephalitis

GenoMed, Inc. has announced that the leading experts in West Nile virus encephalitis in Belarus will collaborate with the Company in treating cases of suspected West Nile virus encephalitis this summer. Belarus, formerly part of the USSR, is now a democratic country of 10.5 million people lying between Poland and Russia; its capital is Minsk.

7 May 2004

West Nile treatment showing 100% response rate among immunocompetent patients

GenoMed, Inc. has announced that it will be limiting its treatment for West Nile virus encephalitis to immunocompetent patients only, where it has posted a 100% success rate.

7 May 2004

Organic superglues, disease treatments and better food flavourings

Organic superglues, disease treatments and better food flavourings: these are some of the projects where synthetic organic chemist Carol Taylor employs her skills.

5 May 2004

New hope for advances in treatment methods for AIDS, Alzheimer's and age-related blindness

Pharmaceutical science leaders from the FDA, research institutions and top pharmaceutical companies will gather at the 2004 AAPS National Biotechnology Conference, AAPS' spring annual meeting.

4 May 2004

Functional genomics and proteomics may accelerate the discovery of new drugs and therapeutic molecules

Functional genomics and proteomics have been quite successful in identifying functions of potential therapeutic targets such as encoded proteins. In fact, the possibilities of identifying more than 10,000 novel target antigens in the human genome may accelerate the discovery of new drugs and therapeutic molecules.

29 Apr 2004